Tripos Shares Up 21 Percent on News It Will Sell Informatics Business | GenomeWeb
NEW YORK (GenomeWeb News) — Shares in Tripos were up 21 percent, or $.13, at $.74 in mid-afternoon trading after the company said it has found a buyer for its Discovery Informatics business.
 
As GenomeWeb News reported this morning, Tripos said it will sell the division to Venture for $26.5 million in cash and it said it expects to distribute between $6 million and $12 million to its shareholders when the sale closes.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.